Trial Profile
Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Saxagliptin (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Therapeutic Use
- Acronyms SAXAswitch
- 01 Jun 2013 New source identified and integrated (European Clinical Trials Database; EudraCT2009-016745-25).
- 29 Sep 2010 New trial record